dibutyryl cyclic-3',5'-cytidine monophosphate has been researched along with losartan potassium in 1 studies
| Studies (dibutyryl cyclic-3',5'-cytidine monophosphate) | Trials (dibutyryl cyclic-3',5'-cytidine monophosphate) | Recent Studies (post-2010) (dibutyryl cyclic-3',5'-cytidine monophosphate) | Studies (losartan potassium) | Trials (losartan potassium) | Recent Studies (post-2010) (losartan potassium) |
|---|---|---|---|---|---|
| 72 | 0 | 18 | 24,390 | 2,493 | 5,408 |
| Protein | Taxonomy | dibutyryl cyclic-3',5'-cytidine monophosphate (IC50) | losartan potassium (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 8.53 | |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0082 | |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0049 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0082 | |
| 5-hydroxytryptamine receptor 1A | Mus musculus (house mouse) | 0.0082 | |
| Type-1 angiotensin II receptor | Cavia porcellus (domestic guinea pig) | 0.018 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batmunkh, C; Hellwig-Bürgel, T; Jelkmann, W; Krajewski, J | 1 |
1 other study(ies) available for dibutyryl cyclic-3',5'-cytidine monophosphate and losartan potassium
| Article | Year |
|---|---|
Erythropoietin production: Molecular mechanisms of the antagonistic actions of cyclic adenosine monophosphate and interleukin-1.
Topics: Blotting, Western; Cells, Cultured; Cyclic AMP; Cyclic CMP; Electrophoretic Mobility Shift Assay; Erythropoietin; GATA2 Transcription Factor; Gene Expression Regulation; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Interleukin-1; NF-kappa B; Promoter Regions, Genetic; RNA, Messenger | 2006 |